References
- Jörgensen H RI, Svanholm H, Høst A. Bone formation induced in an infant by systemic prostaglandin-E2 administration. Acta Orthop Scand 1988; 59(4)464–6
- Heyman E, Laver J, Beer S. Prostaglandin synthetase inhibitor in Caffey's disease: letter. J Pediatr 1982; 101(2)314
- Williams J L. Periosteal hyperostosis resulting from prostaglandin therapy. Eur J Radiol 1986; 6(3)231–2
- Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, Twaya T. Cortical hyperostosis following long term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 1980; 97: 834
- Ringel R E, Brenner J J, Haney P J, Burns J E, Moulton A L, Berman M A. Prostaglandin-induced periostitis. A complication of long-term PGE, infusion in an infant with congenital heart disease. Radiology 1982; 142: 657
- Benz-Baum G, Emons D, Schickendantz S, et al. Cortical hyperostosis caused by longterm prostaglandin E2 therapy. Radiologe 1984; 24: 72–78